Stay updated on Pembrolizumab in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Lymphoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.2%
    Check dated 2025-05-22T03:49:06.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-05-14T23:40:30.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-05-07T19:46:56.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.3%
    Check dated 2025-04-30T14:25:25.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new treatment protocols for patients diagnosed with R/R FL and R/R DLBCL, as well as the introduction of new arms in the study. Key dates for results reporting have also been added.
    Difference
    18%
    Check dated 2025-04-23T13:37:32.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new study identifiers and collaborators, while removing detailed descriptions of the trial's methodology and treatment arms.
    Difference
    55%
    Check dated 2025-04-16T10:39:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Lymphoma Clinical Trial page.